An interventional study of EVO Cognitive Remediation Game in Attention Concentration Difficulty, Depression and Anxiety, sponsored by University of Washington. Completed at 1 site in United States. Per ClinicalTrials.gov, last updated 2018-08-08.
Sponsored by University of Washington · Not applicable, Interventional, and Prevention
The aim of the study is to determine whether a neuroscience-inspired cognitive remediation video game (EVO) that targets the cognitive control network (CCN) will improve executive functioning (EF) and resilience to psychiatric symptoms in typically developing 6th grade students, unselected for specific psychiatric symptoms. The primary goals are to 1) determine if EVO will result in improved EF and lower internalizing (e.g., mood, anxiety) and externalizing (e.g., attention deficit/hyperactivity disorder, AD/HD) psychiatric symptoms, 2) evaluate whether the benefit experienced by youth changes depending on their level of life stress (e.g., academic or social difficulties), 3) determine if EVO will promote resilience to stress. The investigators will measure EF, symptoms, and stress using self- and parent-report questionnaires. Other secondary outcomes include information on behavior in the classroom and academic performance (i.e., grades) that we will collect via school records. The investigators hypothesize that engagement with EVO 20-minutes per day, 5-days a week across 4-weeks will improve EF, lower psychiatric symptoms, improve academic/behavioral functioning at school, and decrease maladaptive responses to stress.
Exclusion Criteria:
All children receive 4 weeks of EVO 5 days/week for 20 minutes per day in a stepped wedge design.
Other: EVO Cognitive Remediation Game
EVO (formerly called Neuroracer) is a neuroscience-inspired plasticity trainings in the form of a video driving game that uses adaptive algorithms and dual-tasking paradigms to target the CCN. Work from our group (Project:EVO) recently showed that 4 weeks of EVO training is associated with increased neural recruitment in brain regions associated with CNN, superior improvement in cognitive control performance (i.e., working memory, sustained attention) when compared to an evidence-based psychotherapy (Problem-Solving Therapy), and improved depression outcomes similar to Problem-Solving Therapy among older adults (Areán, Hallgren, Jordan, Gazzaley, Atkins, Heagerty, \& Anguera, 2016; Journal of Medical Internet Research).
Executive Function
Measuring Executive Function (e.g., attention, working memory) via parent-report of children's symptoms.
Time frame: Measured 5 times across 5 months
Behavioral Problems
Measuring difficulties with attention (i.e., attention deficit/hyperactivity disorder), oppositionality, and conduct at home and school as measured by parent-report on children's behavior.
Time frame: Measured 5 times across 5 months
Depression
depression symptoms measured with self- and parent- report
Time frame: Measured 5 times across 5 months
Anxiety
Measuring self- and parent-reported symptoms of anxiety.
Time frame: Measured 5 times across 5 months
Emotion Regulation
Measuring self-reported cognitive aspects of emotion regulation (e.g., rumination, positive reappraisal).
Time frame: Measured 5 times across 5 months
This study is completed, as verified in Aug 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Washington